Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.7 USD | -6.05% | -16.10% | +41.69% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.69% | 328M | |
-3.10% | 102B | |
+2.11% | 96.37B | |
-1.80% | 21.37B | |
-17.75% | 20.92B | |
-6.91% | 18.64B | |
-42.00% | 16.4B | |
-28.19% | 13.53B | |
+19.90% | 10.85B | |
-23.23% | 8.4B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Piper Sandler Adjusts Price Target on Solid Biosciences to $2 From $5, Maintains Neutral Rating